Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 192 participants.

Also called NCT05081921

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 1/2
Enrolled
  • 192 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05081921
  • EudraCT 2019-005000-17
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Poland (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05081921. Randomized; quadruple masking; primary purpose treatment. Start 2022-01-05 (actual); primary completion 2024-02-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial to Evaluate Safety and Efficacy of MesoCellA-Ortho Tissue-Engineered Advanced Therapy Product in Patients With Osteoarthrosis and Civilisation Diseases
Acronym
BioMiStem-CT
Condition
Osteoarthritis of Knee
Intervention (Drug)
MesoCellA-Ortho administration
Intervention (Drug)
HA administration
Lead sponsor
Jagiellonian University (class: other)
Collaborator
National Center for Research and Development, Poland (class: other)
Collaborator
KCRI (class: other)

Record details

Record id
cardio:ct-nct05081921
Content hash
bcaa422e8055d1d85419d5c5f060b21ce7e14c05a37e58a78fe2093b80180121